• Human Resources
  • Pharmacovigilance
  • Contacts
  • English
  • Português
Laboratórios ATRAL
  • Atral
    • Who are we?
    • Mission and values
    • Atral’s News
  • Atral in the World
  • Services
    • Third Party Production Contract (CMDO)
    • Licensing Out
    • Regulatory – Regulatory Affairs
  • Production
    • General Unit
    • Units of Cephalosporins
    • Penicillins Unit
    • Quality control
  • B. Development
    • Business Development
    • Investigation and development
  • Products
    • Medicinal Products Subject to Medical Prescription
    • Medicinal Products Not Subject to Medical Prescription and Food Supplements
    • Medicinal Products Subject to Medical Prescription
    • Medicinal Products Not Subject to Medical Prescription and Food Supplements
  • General Unit
  • Penicillins Unit
  • Units of Cephalosporins
  • Quality control
  • Business Development
  • Investigation and development

Notícias

26.Sep.2019

  • 21.Nov.2018

    In order to increase competitiveness in the domestic and international...

  • 14.Nov.2018

    At ATRAL Laboratories, we understand that product logistics is not jus...

  • 12.Nov.2018

    Laboratórios Atral launched in March 2017 lymecycline capsules, the f...

  • 09.Nov.2018

    Founded in 1947 Laboratorios Atral entered in a new life cycle, after ...

  • Pharmacovigilance
  • Human Resources
  • Contacts
  • Atral
    • Who are we?
    • Mission and values
    • Atral in the World
  • Services
    • Third Party Production Contract (CMDO)
    • Licensing Out
    • Regulatory – Regulatory Affairs
  • Production
    • General Unit
    • Penicillins Unit
    • Units of Cephalosporins
    • Quality control
  • B. Development
    • Business Development
    • Investigation and development
  • Products
    • Medicinal Products Subject to Medical Prescription
    • Medicinal Products Not Subject to Medical Prescription and Food Supplements
2018 ATRAL. All rights reserved. Made by ActiveMedia
  • Terms of Use
  • Privacy Policy
This website uses cookies to offer you a better experience. For further information, please readTerms of use. OK